Ligand Pharmaceuticals Incorporated
LGND · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4 | $52 | -$33 | $57 |
| Dep. & Amort. | $35 | $37 | $51 | $51 |
| Deferred Tax | -$16 | $12 | $21 | -$9 |
| Stock-Based Comp. | $41 | $26 | $60 | $39 |
| Change in WC | $19 | -$34 | $66 | -$52 |
| Other Non-Cash | $21 | -$42 | -$27 | -$7 |
| Operating Cash Flow | $97 | $50 | $138 | $79 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$4 | -$18 | -$9 |
| Net Acquisitions | -$172 | -$26 | -$1 | $0 |
| Inv. Purchases | -$226 | -$127 | -$51 | -$181 |
| Inv. Sales/Matur. | $270 | $194 | $234 | $221 |
| Other Inv. Act. | -$13 | -$50 | -$1 | -$1 |
| Investing Cash Flow | -$144 | -$12 | $164 | $31 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$77 | -$261 | -$146 |
| Stock Issued | $37 | $0 | $0 | $34 |
| Stock Repurch. | $0 | $0 | -$8 | -$18 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $60 | $17 | -$7 | -$7 |
| Financing Cash Flow | $97 | -$60 | -$276 | -$138 |
| Forex Effect | -$1 | $0 | $0 | $0 |
| Net Chg. in Cash | $49 | -$22 | $25 | -$28 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23 | $45 | $20 | $48 |
| End Cash | $72 | $23 | $45 | $20 |
| Free Cash Flow | $77 | -$4 | $120 | $70 |